Target Name: LOC105375175
NCBI ID: G105375175
Review Report on LOC105375175 Target / Biomarker Content of Review Report on LOC105375175 Target / Biomarker
LOC105375175
Other Name(s): Uncharacterized LOC105375175

LOC105375175: A Potential Drug Target for Various Diseases

LOC105375175 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the LOC105 family of proteins, which are known for their role in intracellular signaling.

Recent studies have identified LOC105375175 as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique expression pattern and structural features make it an attractive target for small molecule inhibitors.

One of the key reasons for the interest in LOC105375175 is its role in intracellular signaling. The LOC105 family of proteins are known for their ability to regulate protein interactions and intracellular signaling pathways. These proteins play a crucial role in maintaining cellular homeostasis and have been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

LOC105375175 has been shown to play a role in several intracellular signaling pathways, including the NF-kappa pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. These pathways are involved in various cellular processes, including cell growth, differentiation, and inflammation.

In addition to its role in intracellular signaling, LOC105375175 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of diseases. For example, studies have shown that LOC105375175 is involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed in the body.

The potential benefits of targeting LOC105375175 are significant. By inhibiting its activity, researchers may be able to reduce the formation of new blood vessels, which can be a therapeutic approach for diseases that are characterized by the formation of new blood vessels, such as cancer, neurodegenerative diseases, and autoimmune disorders.

Another potential approach to targeting LOC105375175 is to use small molecules as inhibitors. Researchers have identified several small molecules that have been shown to inhibit LOC105375175 activity in cell culture and animal models of disease. These molecules have a wide range of structural features, including altered atoms, modified side chains, and altered sizes.

While the use of small molecules as inhibitors is an attractive approach to targeting LOC105375175, there are also concerns about the potential side effects and toxicity of these molecules. To address these concerns, researchers have been investigating the efficacy and safety of small molecules as potential inhibitors of LOC105375175.

In conclusion, LOC105375175 is a protein that has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique expression pattern and structural features make it an attractive target for small molecule inhibitors. Further research is needed to determine the efficacy and safety of small molecules as potential inhibitors of LOC105375175.

Protein Name: Uncharacterized LOC105375175

The "LOC105375175 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105375175 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105375179 | LOC105375186 | LOC105375194 | LOC105375195 | LOC105375199 | LOC105375204 | LOC105375207 | LOC105375218 | LOC105375230 | LOC105375235 | LOC105375236 | LOC105375237 | LOC105375242 | LOC105375264 | LOC105375275 | LOC105375284 | LOC105375291 | LOC105375310 | LOC105375337 | LOC105375340 | LOC105375341 | LOC105375347 | LOC105375361 | LOC105375379 | LOC105375381 | LOC105375404 | LOC105375410 | LOC105375423 | LOC105375428 | LOC105375429 | LOC105375434 | LOC105375440 | LOC105375443 | LOC105375448 | LOC105375451 | LOC105375452 | LOC105375490 | LOC105375492 | LOC105375494 | LOC105375508 | LOC105375523 | LOC105375536 | LOC105375541 | LOC105375543 | LOC105375552 | LOC105375556 | LOC105375567 | LOC105375574 | LOC105375597 | LOC105375600 | LOC105375610 | LOC105375623 | LOC105375629 | LOC105375631 | LOC105375639 | LOC105375655 | LOC105375670 | LOC105375672 | LOC105375683 | LOC105375690 | LOC105375704 | LOC105375712 | LOC105375716 | LOC105375721 | LOC105375725 | LOC105375730 | LOC105375733 | LOC105375739 | LOC105375741 | LOC105375743 | LOC105375745 | LOC105375751 | LOC105375753 | LOC105375755 | LOC105375779 | LOC105375785 | LOC105375787 | LOC105375805 | LOC105375825 | LOC105375836 | LOC105375855 | LOC105375856 | LOC105375861 | LOC105375875 | LOC105375896 | LOC105375903 | LOC105375911 | LOC105375914 | LOC105375920 | LOC105375922 | LOC105375925 | LOC105375928 | LOC105375931 | LOC105375938 | LOC105375943 | LOC105375951 | LOC105375962 | LOC105375974 | LOC105375976 | LOC105375977